Navigation Links
Vestiage Signs Buyside Engagement Agreement with CJK Securities
Date:4/29/2013

Newport Beach, California (PRWEB) April 29, 2013

Vestiage Inc, a publicly traded anti-aging lifestyle company focused on science-based, highly effective premium branded cosmeceuticals and nutraceuticals, announced today that it has signed a buyside agreement with CJK Securities to accelerate the Company's Acquisition Initiative.

"I have known CJK for some time now and they have a fantastic ability to know what we're looking for and to find assets that nobody else knows about that fit our Acquisition Initiative and our niche well", said Scott Kimball, CEO of Vestiage. "They also know our philosophy and Vestiage well. They are highly responsive and professional. Working with them has always been easy and a pleasure for us."

For more information on the Vestiage Acquisition Initiative, please visit the Company website.

About Vestiage
Vestiage is a leading publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean based and patented botanically-based ingredients and science to produce potent and effective products using clinically proven ingredients. Using high potency and novel ingredient combinations allows Vestiage to offer highly effective cosmeceuticals such as Reluma, and multifunctional nutraceuticals through Monterey Bay Nutraceuticals. Vestiage brands address the top “in demand” anti-aging consumer concerns. To learn more, visit the Company website.

About CJK Securities
CJK Securities, Inc. is a licensed broker-dealer member of FINRA that provides financial advisory services to Middle Market companies whether owned by a family, several investors, or by a venture capital or private equity firm. During their careers, the CJK team has completed over $2 billion of sell-side, buy-side and capital formation transactions. CJK provides focused, personalized and responsive service while working closely with our clients' personnel to bring transactions to a successful close. For more information, visit http://www.CJKsecurities.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10640048.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vestiage Announces Key Partners for Launch of Monterey Bay Nutraceuticals Anti-Aging Wellness Products
2. Vestiage Announces Filing of Disclosure Statement with Exchange
3. Vestiage CEO Comments on Immortal Life
4. Vestiage to Partner with Skincare By Alana
5. Vertilon Signs Crisel Instruments as its Distributor in Italy
6. Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine
7. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
8. Samsung Thales signs Development Agreement with Novelda
9. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
10. Algae.Tec Signs MOU with WorleyParsons for Global Project Development Program
11. Quadrant Engineering Plastic Products Assigns Production of Acetron® GP and Nylon 101 Hex/Square Rods to Atlas Fibre Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Grove, CA (PRWEB) , ... December 09, 2016 , ... ... Top Workplace for 2016 by the Orange County Register, after winning the award last ... company is a sought-after employer. President and COO Daniel Vesely pointed to the tech ...
(Date:12/9/2016)... , December 9, 2016 The ... top five players in the  Global Label-Free Array Systems ... overall market in 2015. Players such as Biacore, Agilent ... remained dominant in the global market due to their ... product innovation. Product upgrades and timely product launches are ...
(Date:12/9/2016)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") ... announce that Biohaven has issued today the following press ... (PRWEB) Dec 9, 2016 - Biohaven Pharmaceutical Holding ... the U.S. Food and Drug Administration ("FDA") has granted ... candidate BHV-0223, an orally dissolving tablet being developed for ...
(Date:12/8/2016)... , Dec. 8, 2016 This report analyzes the ... Segments: Acid Based (Humic, Amino, & Fulvic), Extract Based, and ... following Crop Types: Ornamental & Turf, Row Crops, and Others. ... Canada , Japan , ... Latin America , and Rest of World. Annual ...
Breaking Biology Technology:
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market ... Application Area, End User, And Region - Global Forecast to 2021", published by ... 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... 7, 2016   Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
Breaking Biology News(10 mins):